American Well Corp Stock Price, News & Analysis

Amwell (NYSE: AMWL) has announced the launch of its new cardiometabolic program, enhancing its ecosystem of digital health solutions to better serve members with chronic diseases like diabetes and high blood pressure. This initiative, in partnership with DarioHealth (Nasdaq: DRIO), integrates Dario's personalized digital therapeutic solutions into the Amwell platform, facilitating seamless referrals for clinicians. The program aims to improve health outcomes by ensuring continuous care and engagement for over one-third of Americans living with metabolic conditions. Through connected devices and coaching, members experience a holistic approach to managing their health.

Amwell (NYSE: AMWL) reported its Q4 and full-year 2022 financial results, revealing a total revenue of $79.2 million for Q4, up 9% year-over-year. Subscription revenue reached $30.7 million, and AMG Visit revenue was $35.1 million, contributing to a gross margin of 42.4%. Although the net loss narrowed to $61.6 million from the previous quarter's $70.6 million, adjusted EBITDA remained negative at ($43.4) million. Active providers surged 11% to approximately 107,000, with total visits increasing to 1.7 million, up 10%. The company projects revenue between $275 and $285 million for 2023, reflecting ongoing growth.

Amwell (NYSE: AMWL), a leader in digital healthcare, announces CFO Robert Shepardson will participate in a fireside chat at the Cowen 43rd Annual Healthcare Conference on March 7, 2023, at 9:10 AM ET. A follow-up audio webcast will be available afterward on their investor relations page. Amwell aims to enhance digital care delivery, connecting providers, insurers, patients, and innovators to improve access to quality care. The company supports over 2,000 hospitals and 55 health plan partners, covering over 80 million lives with its comprehensive digital health solutions.

Amwell (NYSE: AMWL), a digital healthcare leader, announced it will report its fourth quarter operating results for the period ending December 31, 2022, on February 22, 2023, at 5:00 p.m. Eastern Time. Following the earnings release, the management team will host a live conference call and webcast to discuss results and provide business updates. Access to the webcast will be available on the company's investor relations website. Amwell connects healthcare providers, insurers, and patients, serving over 80 million lives through its digital care platform.

Amwell® (NYSE: AMWL) announced its third-quarter financial results for 2022, reporting a total revenue of $69.2 million, an 11% increase from $62.2 million in Q3 2021. Subscription revenue grew by 19% to $31.9 million, while AMG Visit revenue was $28.8 million. Gross margin stood at 40%. The net loss was ($70.6 million), slightly higher than the ($69.7 million) loss in Q2 2022. Active providers increased by 23% to 98,500. The company expects to meet its annual revenue guidance of $275 to $285 million and has refined its Adjusted EBITDA outlook to between ($180) million and ($190) million.

Amwell (NYSE: AMWL) announced the appointment of Robert Webb to its Board of Directors, effective immediately. With over 30 years of experience in healthcare technology, Mr. Webb aims to enhance Amwell's market position and growth trajectory. His previous roles include CEO of Optum's consumer network and President of UnitedHealth Group Ventures. Amwell focuses on digital healthcare enablement, connecting various stakeholders to improve care accessibility and quality. The company supports over 2,000 hospitals and 55 health plan partners, impacting over 80 million lives.

BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital healthcare leader, announced key participation in upcoming investor conferences. On November 10, 2022, CEO Dr. Ido Schoenberg and CFO Bob Shepardson will attend the Credit Suisse Healthcare Conference, hosting a fireside chat at 8:30 a.m. PT. Shepardson will also engage in meetings at the Needham & Co. Virtual Health Tech One-on-One Conference on November 15 and at BTIG's Virtual Healthcare Day on November 21. They will meet investors again on November 30 at the Piper Sandler Healthcare Conference in New York City.

Amwell (NYSE: AMWL) will report third-quarter operating results for the period ending September 30, 2022, on November 7, 2022. Following the earnings release, management will host a live conference call at 5:00 PM ET to discuss the results and provide a business update. Investors can access the webcast on the company's website or by calling U.S. and international numbers. Amwell is a leading digital healthcare platform, enabling improved access to affordable care, serving over 2,000 hospitals and covering more than 80 million lives.

Amwell (NYSE: AMWL) announces key executive appointments, bringing a combined 40 years of experience to its leadership team. Vaughn Paunovich joins as Executive Vice President of Enterprise Platforms, focusing on technological delivery and innovation for the Converge platform. Matthew McAllister takes on the role of Chief Product Officer, overseeing product management and design. CEO Roy Schoenberg emphasized the importance of these roles amidst the digital transformation in healthcare, positioning Amwell as a partner in meeting customer needs for integrated technological solutions.